FDA Approved: ARIPIPRAZOLE — Supplemental Application (Lannett Company, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Lannett's generic aripiprazole, authorizing a generic formulation of the antipsychotic.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder
• Bipolar Disorder
• Major Depressive Disorder
• Schizophrenia

Drugs mentioned

• Aripipazole (Aripiprazole)

Snippet

SUPPL AP for ARIPIPRAZOLE (ARIPIPRAZOLE)